Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.1.1.34 extracted from

  • Shimizu, Y.; Hishiki, T.; Sugiyama, K.; Ogawa, K.; Funami, K.; Kato, A.; Ohsaki, Y.; Fujimoto, T.; Takaku, H.; Shimotohno, K.
    Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins (2010), Virology, 407, 152-159.
    View publication on PubMed

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
very low density lipoprotein + H2O Bos taurus
-
intermediate density lipoprotein + ?
-
?

Organism

Organism UniProt Comment Textmining
Bos taurus
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
very low density lipoprotein + H2O
-
Bos taurus intermediate density lipoprotein + ?
-
?

Synonyms

Synonyms Comment Organism
LPL
-
Bos taurus

General Information

General Information Comment Organism
physiological function lipoprotein lipase (LPL) reduces the infectivity of hepatitis C virus through its catalytic activity on hepatitis C virus-associated lipoproteins. LPL treatment reduces association of hepatitis C virus with ApoE Bos taurus